Table 3.

The values of salivary and serum anti-Dsg 1 and anti-3 ELISA in PV patients regarding their phenotype and controls.

Disease phenotype	Salivary ELISA		Serum ELISA
	Anti-Dsg1*	Anti-Dsg3*	Anti-Dsg1*	Anti-Dsg3*
	Median (IQR**)	Median (IQR)	Median (IQR)	Median (IQR)
Mucosal	1.80 (1.3–6.9)	21 (8.3–92)	3.2 (2.3–28)	163 (40–322)
Cutaneous	2.40 (1.75–80.4)	3.8 (1.6–14.8)	186 (94.15–376.5)	165 (32.15–358.5)
Mucocutaneous	17.35 (2.15–114.25)	182 (35.75–255)	136 (58.5–241.75)	310 (244.5–399.25)
Overall	8.4 (1.7–75.25)	102.5 (16.925–215.25)	90 (12.225–213.25)	297 (200.25–382)
Controls	2 (1.6–3.1)	2.1 (1.4–4.8)	1.5 (1.1–1.9)	1.2 (1.1–1.6)

  ^*The unit for measurement is RU/mL.

^**Interquartile range.